{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:15:50Z","timestamp":1791850550619,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0453-7","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T11:18:53Z","timestamp":1444735133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Rivaroxaban versus Aspirin for Non-disabling Cerebrovascular Events (TRACE): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Fang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"issue":"7","key":"453_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","volume":"20","author":"T Brott","year":"1989","unstructured":"Brott T, Adams Jr HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864\u201370.","journal-title":"Stroke"},{"issue":"6","key":"453_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/ageing\/afm088","volume":"36","author":"MF Giles","year":"2007","unstructured":"Giles MF, Rothwell PM. Substantial underestimation of the need for outpatient services for TIA and minor stroke. Age Ageing. 2007;36(6):676\u201380.","journal-title":"Age Ageing"},{"issue":"6","key":"453_CR3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1197\/j.aem.2006.01.014","volume":"13","author":"JA Edlow","year":"2006","unstructured":"Edlow JA, Kim S, Pelletier AJ, Camargo Jr CA. National study on emergency department visits for transient ischemic attack, 1992\u20132001. Acad Emerg Med. 2006;13(6):666\u201372.","journal-title":"Acad Emerg Med"},{"issue":"7435","key":"453_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/bmj.37991.635266.44","volume":"328","author":"AJ Coull","year":"2004","unstructured":"Coull AJ, Lovett JK, Rothwell PM, Oxford Vascular S. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328(7435):326.","journal-title":"BMJ"},{"issue":"22","key":"453_CR5","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","volume":"284","author":"SC Johnston","year":"2000","unstructured":"Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901\u20136.","journal-title":"JAMA"},{"issue":"4","key":"453_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(06)70408-2","volume":"5","author":"PM Rothwell","year":"2006","unstructured":"Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol. 2006;5(4):323\u201331.","journal-title":"Lancet Neurol"},{"issue":"12","key":"453_CR7","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1161\/01.STR.0000101752.23813.C3","volume":"34","author":"GD Graham","year":"2003","unstructured":"Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke. 2003;34(12):2847\u201350.","journal-title":"Stroke"},{"issue":"2","key":"453_CR8","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1161\/01.STR.0000109767.11426.17","volume":"35","author":"D Kleindorfer","year":"2004","unstructured":"Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke. 2004;35(2):e27\u201329.","journal-title":"Stroke"},{"issue":"9","key":"453_CR9","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1161\/STROKEAHA.106.480566","volume":"38","author":"J Keyser De","year":"2007","unstructured":"De Keyser J, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007;38(9):2612\u20138.","journal-title":"Stroke"},{"issue":"11","key":"453_CR10","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1161\/01.STR.0000185798.78817.f3","volume":"36","author":"EE Smith","year":"2005","unstructured":"Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke. 2005;36(11):2497\u20139.","journal-title":"Stroke"},{"issue":"9066","key":"453_CR11","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","volume":"349","author":"ZM Chen","year":"1997","unstructured":"Chen ZM, Group CC. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 1997;349(9066):1641\u20139.","journal-title":"Lancet"},{"issue":"9065","key":"453_CR12","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","volume":"349","author":"International Stroke Trial Collaborative Group","year":"1997","unstructured":"International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349(9065):1569\u201381.","journal-title":"Lancet"},{"issue":"16","key":"453_CR13","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa060989","volume":"354","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706\u201317.","journal-title":"N Engl J Med"},{"issue":"9","key":"453_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/NEJMoa1204133","volume":"367","author":"OR Benavente","year":"2012","unstructured":"S.P.S. Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012;367(9):817\u201325.","journal-title":"N Engl J Med"},{"issue":"1","key":"453_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"453_CR16","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1161\/01.STR.0000072275.34976.73","volume":"34","author":"Esprit","year":"2003","unstructured":"Esprit. Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage. Stroke. 2003;34(6):e45\u201346.","journal-title":"Stroke"},{"issue":"13","key":"453_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa043033","volume":"352","author":"MI Chimowitz","year":"2005","unstructured":"Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305\u201316.","journal-title":"N Engl J Med"},{"issue":"20","key":"453_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa011258","volume":"345","author":"JP Mohr","year":"2001","unstructured":"Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345(20):1444\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"453_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000092331","volume":"22","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, Prabhakaran S, Thompson JL, Murphy A, Sciacca RR, Levin B, et al. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis. 2006;22(1):4\u201312.","journal-title":"Cerebrovasc Dis"},{"issue":"12","key":"453_CR20","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1161\/STR.0b013e318266722a","volume":"43","author":"KL Furie","year":"2012","unstructured":"Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP, et al. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2012;43(12):3442\u201353.","journal-title":"Stroke"},{"issue":"10","key":"453_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"issue":"11","key":"453_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981\u201392.","journal-title":"N Engl J Med"},{"issue":"6","key":"453_CR23","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1161\/STROKEAHA.111.000402","volume":"44","author":"AR Harrington","year":"2013","unstructured":"Harrington AR, Armstrong EP, Nolan Jr PE, Malone DC. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation. Stroke. 2013;44(6):1676\u201381.","journal-title":"Stroke"},{"issue":"8","key":"453_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/jme.2005.013722","volume":"32","author":"P Allmark","year":"2006","unstructured":"Allmark P, Mason S. Improving the quality of consent to randomised controlled trials by using continuous consent and clinician training in the consent process. J Med Ethics. 2006;32(8):439\u201343.","journal-title":"J Med Ethics"},{"issue":"3","key":"453_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams Jr HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44(3):870\u2013947.","journal-title":"Stroke"},{"issue":"7","key":"453_CR26","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45(7):2160\u2013236.","journal-title":"Stroke"},{"issue":"16","key":"453_CR27","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jama.279.16.1265","volume":"279","author":"The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators","year":"1998","unstructured":"The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA. 1998;279(16):1265\u201372.","journal-title":"JAMA"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0453-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0453-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0453-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:07:48Z","timestamp":1718132868000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0453-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0453-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]},"article-number":"195"}}